THERADIAG Announces That BIOSYNEX Has Filed a Voluntary Takeover Bid for Its Shares

« Theradiag, a company specializing in in vitro diagnostics and Theranostics, announces that Biosynex has filed with the French financial markets authority (the “Autorité des marchés financiers”, the “AMF”) a voluntary takeover bid offer for the shares of the Company that it does not own, at a price of 2.30 euros per share (the “Offer”). »